CSO- Fast Growing - AI-Driven Pharmaceutical Company
发布于: 07/08/2026
Shanghai East China
CNY 2000K - 5000K 每年
Permanent
生命科学、医疗保健、制药
About the Company
- We are a rapidly growing, AI-driven biotechnology company leveraging advanced computational platforms, machine learning, and biological data science to accelerate the discovery and development of next-generation therapeutics.
- The company is building a differentiated pipeline in immunology and immune-related diseases, with a strong commitment to scientific innovation, translational excellence, and rapid execution.
About the Job
- Serve as Chief Scientific Officer (CSO) and provide overall scientific vision, strategy, and leadership for the organization's immunology-focused research and development efforts.
- Define and execute long-term scientific and portfolio strategies to maximize pipeline value and achieve key development milestones.
- Lead the integration of AI/ML capabilities with biology, translational science, and drug discovery activities.
- Oversee target identification, validation, mechanism-of-action research, biomarker strategy, and preclinical development programs.
- Establish and guide research priorities across immunology, inflammation, autoimmune diseases, and related therapeutic areas.
- Build, mentor, and scale world-class multidisciplinary scientific teams across biology, computational science, translational medicine, and drug development.
- Work closely with executive leadership and the Board to shape corporate strategy, investment priorities, and growth plans.
- Drive scientific decision-making and portfolio governance through data-driven evaluation and risk assessment.
- Develop and maintain relationships with key opinion leaders, academic institutions, strategic partners, and industry collaborators.
- Represent the company at scientific conferences, investor meetings, partnering discussions, and external scientific forums.
- Guide IND-enabling activities and support regulatory interactions where appropriate.
- Foster a culture of innovation, collaboration, scientific rigor, and operational excellence.
Required Qualifications
- PhD, MD, or MD/PhD in Immunology, Biology, Medicine, or a related life sciences discipline.
- 15+ years of progressive leadership experience within biotechnology, pharmaceutical, or innovative life sciences organizations.
- Recognized scientific leader with deep expertise in immunology, inflammation, autoimmune disease, or immune-mediated disorders.
- Proven track record of advancing drug discovery programs from target identification through preclinical and/or clinical development.
- Experience leading large scientific organizations and managing senior research leaders.
- Strong understanding of translational science, biomarkers, and modern therapeutic modalities.
- Demonstrated success in integrating cutting-edge technologies, including AI, computational biology, genomics, or data science, into drug discovery.
- Experience working with external collaborators, academic investigators, and strategic partners.
- Strong business acumen with the ability to balance scientific innovation and commercial objectives.
- Excellent communication and presentation skills, with the ability to influence investors, Board members, and external stakeholders.
- Experience in venture-backed, high-growth, or entrepreneurial biotech environments preferred.
- Proven ability to attract, develop, and retain top scientific talent.
Why This Opportunity?
- Opportunity to shape the scientific direction of a high-growth AI-native biotechnology company at a pivotal stage of expansion.
- Lead a highly innovative platform combining artificial intelligence with breakthrough immunology research.
- Significant influence on corporate strategy, pipeline development, and long-term value creation.
- Work alongside an experienced leadership team, leading investors, and top-tier scientific collaborators.
- Competitive executive compensation package, including meaningful long-term equity participation.